These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30850318)

  • 1. Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology.
    Menchon JM; Bobes J; Alamo C; Alonso P; García-Portilla MP; Ibáñez Á; Real E; Bousoño M; Saiz-Gonzalez MD; Saiz-Ruiz J
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(2):77-91. PubMed ID: 30850318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To What Extent do Clinical Practice Guidelines Respond to the Needs and Preferences of Patients Diagnosed with Obsessive-Compulsive Disorder?
    Villena-Jimena A; Gómez-Ocaña C; Amor-Mercado G; Núñez-Vega A; Morales-Asencio JM; Hurtado MM
    Rev Colomb Psiquiatr (Engl Ed); 2018; 47(2):98-107. PubMed ID: 29754712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepidemiology of obsessive-compulsive disorder: A Swedish nationwide cohort study.
    Isomura K; Nordsletten AE; Rück C; Ljung R; Ivarsson T; Larsson H; Mataix-Cols D
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):693-704. PubMed ID: 26922101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic treatment of obsessive compulsive disorders.
    Jenike MA
    Psychiatr Clin North Am; 1992 Dec; 15(4):895-919. PubMed ID: 1461804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medical treatment of obsessive-compulsive disorder and anxiety.
    Bandelow B
    CNS Spectr; 2008 Sep; 13(9 Suppl 14):37-46. PubMed ID: 18849910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive disorder: The usefulness of a pharmacological practice guideline.
    Menchón JM; Bobes J; Saiz-Ruiz J
    Rev Psiquiatr Salud Ment; 2016; 9(3):131-3. PubMed ID: 27368427
    [No Abstract]   [Full Text] [Related]  

  • 7. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.
    Bandelow B; Zohar J; Hollander E; Kasper S; Möller HJ; ; Zohar J; Hollander E; Kasper S; Möller HJ; Bandelow B; Allgulander C; Ayuso-Gutierrez J; Baldwin DS; Buenvicius R; Cassano G; Fineberg N; Gabriels L; Hindmarch I; Kaiya H; Klein DF; Lader M; Lecrubier Y; Lépine JP; Liebowitz MR; Lopez-Ibor JJ; Marazziti D; Miguel EC; Oh KS; Preter M; Rupprecht R; Sato M; Starcevic V; Stein DJ; van Ameringen M; Vega J
    World J Biol Psychiatry; 2008; 9(4):248-312. PubMed ID: 18949648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review.
    Choi YJ
    J Am Acad Nurse Pract; 2009 Apr; 21(4):207-13. PubMed ID: 19366379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of psychotropic agents for the symptoms of obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Moses K; Hannan A; Sammut P; Martin A
    Australas Psychiatry; 2013 Apr; 21(2):117-21. PubMed ID: 23426097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.
    Marinova Z; Chuang DM; Fineberg N
    Curr Neuropharmacol; 2017; 15(7):977-995. PubMed ID: 28322166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialized psychological and pharmacological treatments for obsessive-compulsive disorder throughout the lifespan: a special series by the Accreditation Task Force (ATF) of The Canadian Institute for Obsessive Compulsive Disorders (CIOCD, www.ciocd.ca).
    Sookman D; Fineberg NA;
    Psychiatry Res; 2015 May; 227(1):74-7. PubMed ID: 25661530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug treatment of obsessive-compulsive disorder. With proper drugs and some patience many patients can be helped].
    Mavrogiorgou P; Hegerl U
    MMW Fortschr Med; 1999 Sep; 141(39):32-4, 37. PubMed ID: 10897982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of obsessive-compulsive disorder. The Expert Consensus Panel for obsessive-compulsive disorder.
    J Clin Psychiatry; 1997; 58 Suppl 4():2-72. PubMed ID: 9183300
    [No Abstract]   [Full Text] [Related]  

  • 14. Approaches to the patient with treatment-refractory obsessive compulsive disorder.
    Jenike MA
    J Clin Psychiatry; 1990 Feb; 51 Suppl():15-21. PubMed ID: 2404966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcosine therapy for obsessive compulsive disorder: a prospective, open-label study.
    Wu PL; Tang HS; Lane HY; Tsai CA; Tsai GE
    J Clin Psychopharmacol; 2011 Jun; 31(3):369-74. PubMed ID: 21508860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study.
    Arabzadeh S; Shahhossenie M; Mesgarpour B; Rezaei F; Shalbafan MR; Ghiasi Z; Akhondzadeh S
    Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28485008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation and treatment-resistant obsessive-compulsive disorder: A systematic review.
    Vázquez-Bourgon J; Martino J; Sierra Peña M; Infante Ceberio J; Martínez Martínez MÁ; Ocón R; Menchón JM; Crespo Facorro B; Vázquez-Barquero A
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(1):37-51. PubMed ID: 28676437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
    Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mindfulness-based interventions in obsessive-compulsive disorder: Mechanisms of action and presentation of a pilot study].
    Gasnier M; Pelissolo A; Bondolfi G; Pelissolo S; Tomba M; Mallet L; N'diaye K
    Encephale; 2017 Dec; 43(6):594-599. PubMed ID: 27887679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?].
    van Ingen Schenau WJ; Wisman PW
    Tijdschr Psychiatr; 2007; 49(5):315-25. PubMed ID: 17492582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.